Skip to main content
Fig. 4 | Cancer Cell International

Fig. 4

From: Low-dose zoledronate for the treatment of bone metastasis secondary to prostate cancer

Fig. 4

Migration (Falcon™ insert assay) of LAPC4 (a and b) and prostate-induced bone metastasis cells (c and d) treated with vehicle (PBS1x) or zol 1 µM, 3 µM and 10 µM for 7 days in 1% serum conditions. Representative images of LAPC4 (a) and prostate-induced bone metastasis patient cells (c) cells from vehicle or zol-treated conditions. The histograms represent the ratio of drug-treated cells divided by vehicle-treated cells (PBS1x) for LAPC4 (b) and prostate-induced bone metastasis cells (d). Results are the mean ± SD of three independent experiments, p < 0.05. Scale bar 100 µm

Back to article page